Argent BioPharma Limited
RGTLF
$0.0599
$0.011423.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | -18.29% | -0.21% | -49.07% | 0.47% |
| Total Depreciation and Amortization | -2.74% | -1.19% | 0.24% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.75% | 66.21% | 0.21% | 640.93% | 0.48% |
| Change in Net Operating Assets | -- | -- | -0.20% | -- | -- |
| Cash from Operations | 2.74% | 35.67% | -0.21% | 13.76% | 0.48% |
| Capital Expenditure | 12.50% | 98.03% | -0.25% | -636.36% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 12.50% | 98.03% | -0.25% | -636.36% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -14.94% | 0.00% | 2.48% | 0.00% |
| Issuance of Common Stock | 0.00% | 333.69% | 0.00% | -92.83% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -219.47% | 0.00% | 126.61% | 0.00% |
| Cash from Financing | -2.75% | 295.06% | 0.19% | -92.11% | -0.47% |
| Foreign Exchange rate Adjustments | 0.00% | -21.05% | 0.00% | -211.76% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.92% | 100.27% | -0.21% | -193.43% | -0.47% |